New long‑term results from the RUBY clinical trial show that adding immunotherapy (dostarlimab) to chemotherapy may help some ...

Around 97% of patients with advanced pancreatic cancer die within five years. Researchers have figured out a way to target ...

Novel gedatolisib is currently under review at FDA for wild-type patients ...

Patients in El Paso with certain abdominal cancers now have access to a highly specialized treatment option closer to home ...

For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...

Immunotherapy wipes out some colorectal tumors without surgery, signaling a major shift toward less invasive treatment.

Healthcare providers are increasingly adopting advanced diagnostic and treatment approaches as prostate cancer remains one of ...

People with advanced lung cancer represent a distinct group whose needs remain understudied, especially compared with people diagnosed with limited-stage disease. Fortunately, novel treatments such as ...

Advanced screenings and longevity assessments are gaining traction in preventive health. But the value is more nuanced, according to Mayo Clinic’s Dr. Liz Gilman. In this Q&A, she shares where these ...

A significant discordance exists between patient preferences and received care in advanced cancer, with 37% receiving life-extending treatment despite preferring comfort-focused care. No survival ...

By Dennis Thompson HealthDay ReporterTUESDAY, June 2, 2026 (HealthDay News) — A smartphone app can help individuals with ...